Sublingual buccal effervescent

Details Sublingual buccal effervescent Sublingual buccal effervescent

2005-12-13

2005-12-13

Kunz, Gary (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S464000, C424S465000, C424S715000, C424S717000, C514S315000, C514S317000, C514S329000

Reexamination Certificate

active

06974590

ABSTRACT:
A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.

REFERENCES:
patent: 1262888 (1918-04-01), Preble et al.
patent: 3577490 (1971-05-01), Welsh et al.
patent: 3888976 (1975-06-01), Milvy et al.
patent: 3961041 (1976-06-01), Nishimura et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4147768 (1979-04-01), Shaffer et al.
patent: 4187286 (1980-02-01), Marcus
patent: 4289751 (1981-09-01), Windheuser
patent: 4493848 (1985-01-01), LaHann et al.
patent: 4503031 (1985-03-01), Glassman
patent: 4599342 (1986-07-01), LaHann
patent: 4639368 (1987-01-01), Niazi et al.
patent: 4671953 (1987-06-01), Stanley et al.
patent: 4756710 (1988-07-01), Bondi et al.
patent: 4853211 (1989-08-01), Kurobe et al.
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5028411 (1991-07-01), Callingham et al.
patent: 5053396 (1991-10-01), Blass
patent: 5073374 (1991-12-01), McCarty
patent: 5135752 (1992-08-01), Snipes
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5223264 (1993-06-01), Wehling et al.
patent: 5458879 (1995-10-01), Singh et al.
patent: 5468504 (1995-11-01), Schaeffer
patent: 5503846 (1996-04-01), Wehling et al.
patent: 5559096 (1996-09-01), Edwards et al.
patent: 5607697 (1997-03-01), Alkire et al.
patent: 5624687 (1997-04-01), Yano et al.
patent: 5626866 (1997-05-01), Ebert et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5656284 (1997-08-01), Balkin
patent: 5853748 (1998-12-01), New
patent: 5900252 (1999-05-01), Calanchi et al.
patent: 5952004 (1999-09-01), Rudnic et al.
patent: 5958455 (1999-09-01), Roser et al.
patent: 5958458 (1999-09-01), Norling et al.
patent: 6034085 (2000-03-01), Joshi et al.
patent: 6068853 (2000-05-01), Giannos et al.
patent: 6071539 (2000-06-01), Robinson et al.
patent: 6117912 (2000-09-01), DiSanto
patent: 6129906 (2000-10-01), Steventon
patent: 6200604 (2001-03-01), Pather et al.
patent: 6242002 (2001-06-01), Tritthart et al.
patent: 6264981 (2001-07-01), Zhang et al.
patent: 6316027 (2001-11-01), Johnson et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6326384 (2001-12-01), Whittle et al.
patent: 6350470 (2002-02-01), Pather et al.
patent: 6391335 (2002-05-01), Pather et al.
patent: 6488961 (2002-12-01), Robinson et al.
patent: 6509036 (2003-01-01), Pather et al.
patent: 6576250 (2003-06-01), Pather et al.
patent: 0 197 504 (1986-10-01), None
patent: 0 354 973 (1990-02-01), None
patent: 0361680 (1990-04-01), None
patent: 2307857 (1997-06-01), None
patent: WO 91/04757 (1991-04-01), None
patent: WO 95/27482 (1995-10-01), None
patent: WO-95/34291 (1995-12-01), None
patent: WO 96/29993 (1996-10-01), None
patent: WO-97/17067 (1997-05-01), None
patent: WO 99/49842 (1999-10-01), None
patent: WO 00/35418 (2000-06-01), None
James W. Conine, Special Tablets, in Pharmaceutical Dosage Forms: Tablets vol. 1, 329 (Herbert A. Lieberman et al. eds, 1989).
Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review), American Academy of Pediatrics Committee on Drugs, Pediatrics, vol. 100, No. 1 Jul. 1997, 143, 147.
Squier, C.A., and Wertz, P.W., “Structure and Function of the Oral Mucosa and Implications for Drug Delivery”Oral Mucosal Drug Delivery, Ch. 1, pp. 1-19 (1996).
Wertz et al. “Biochemical Basis of the Permeability Barrier in Skin and Oral Mucosa”Oral Mucosal Drug Delivery, Ch. 2, pp. 27-41 (1996).
Zhang, H., and Robinson, J.R., “Routes of Drug Transport Across Oral Mucosa”Oral Mucosal Drug Delivery, Ch. 3, pp. 51-61 (1996).
Aungst, B.J., “Oral Mucosal Permeation Enhancement: Possibilities and Limitations”Oral Mucosal Drug Delivery, Ch. 4, pp. 65-81 (1996).
Zhang, H., and Robinson, J.R., “In Vitro Methods for Measuring Permeability of the Oral Mucosa”Oral Mucosal Drug Delivery, Ch. 5, pp. 85-97 (1996).
Audus, K.L., “Buccal Epithelial Cell Cultures as a Model to Study Oral Mucosal Drug Transport and Metabolism”Oral Mucosal Drug Delivery, Ch. 6, pp. 101-115 (1996).
Rathbone et al. “In Vivo Techniques for Studying the Oral Mucosal Absorption Characteristics of Drugs in Animals and Humans”Oral Mucosal Drug Delivery, Ch. 7, pp. 121-151 (1996).
Weatherell et al., “The Flow of Saliva and its Influence on the Movement, Deposition, and Removal of Drugs Administered to the Oral Cavity”Oral Mucosal Drug Delivery, Ch. 8, pp. 157-187 (1996).
Schenkels et al., “Salivary Mucins: Their Role in Oral Mucosal Barrier Function and Drug Delivery”Oral Mucosal Drug Delivery, Ch. 9, pp. 191-211 (1996).
Eichman, J.D., Thesis “Mechanistic Studies on Effervescent-Induced Permeability Enhancement” (catalogued at the University of Wisconsin-Madison on Sep. 18, 1998) (on file with the University of Wisconsin-Madison).
Rassing, R., “Specialized Oral Mucosal Drug Delivery Systems: Chewing Gum”Oral Mucosal Drug Delivery, Ch. 13, pp. 319-353 (1996).
Soskolone, W.A., and Friedman, M., “Intra-periodontal Pocket Drug Delivery Systems”Oral Mucosal Drug Delivery, Ch. 14, pp. 359-373 (1996).
Eichman, J.D., and Robinson, J.R., “Mechanistic Studies on Effervescent-Induced Permeability Enhancement” Pharm. Res. 15(6):925-30 (1998).
Kellaway, I.W., and Warren S.J., “Mucoadhesive Hydrogels for Buccal Delivery”Oral Mucosal Drug Delivery, Ch. 10, pp. 221-237 (1996).
Rathbone et al., “Systemic Oral Mucosal Drug Delivery and Delivery Systems”Oral Mucosal Drug Delivery, Ch. 11, pp. 241-275 (1995).
DeGrande et al., “Specialized Oral Mucosal Drug Delivery Systems: Patches”Oral Mucosal Drug Delivery, Ch. 12, pp. 285-313 (1998).
Ranade, V.V.; Drug Delivery Systems Part 5B. Oral Drug Delivery, The Journal of Clinical Pharmacology, Feb. 1991, pp. 98-115, vol. 31.
Giannos, S.A.; Dinh, S.M.; Berner, B.; Temporally Controlled Drug Delivery Systems: Coupling of pH Oscillators with Membrane Diffusion, Journal of Pharmaceutical Sciences, May 1995, pp. 539-543, vol. 84, No. 5.
Amighi, K.; Timmermans, J.; Puigdevall, J.; Baltes, E.; Moës, A.. J.; Peroral Sustained-Released Film-Coated Pellets as a Means to Overcome Physicochemical and Biological Drug-Related Problems. I. In Vitro Development and Evaluation, Drug Development and Industrial Pharmacy, 1998, pp. 509-515, vol. 24, no. 6.
Sorasuchart, W.; Wardrop, J.; Ayers, J.; Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods, Drug Development and Industrial Pharmacy, 1999, pp. 1093-1098, vol. 25, No. 10.
Berko, S.; Regdon Jun, G.; Erös, I.; Influence of pH Change on Drug Release from Rectal Suppositories, Die Pharmazie, Apr. 2000, p. 324, vol. 55., Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn.
Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R.; pH-Independent Release of a Weakly Basic Drug from Water-Insoluble and -Soluble Matrix Tablets, Journal of Controlled Release, 2000, pp. 101-110, vol. 67.
Sasahara et al., “Dosage Form Design for Improvement of Bioavailibity of Levodopa IV: Possible Causes of Low Bioavailability of Oral Levodopa in Dogs” J. Pharm. Sci. 70(7):730-33 (1981).
Nishimura et al., “Dosage Form Design for Improvement of Bioavailability of Levodopa VI: Formulation of Effervescent Enteric-Coated Tablets” J. Pharm. Sci. 73(7):942-46 (1984).

Affiliated with

Also associated with

Rating

Sublingual buccal effervescent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sublingual buccal effervescent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual buccal effervescent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3481932